Adult Relapsed Refractory B-cell Acute Lymphoblastic Leukemia: 2021 Updates

home / insights / adult-relapsed-refractory-b-cell-acute-lymphoblastic-leukemia-2021-updates

Recommendations for assessing and treating patients with relapsed/refractory B-cell ALL based on more recent data presented at ASH 2021.

acute lymphoblastic leukemia

EP. 1: Relapsed Refractory B-Cell ALL: Patient Prognosis

Elias Jabbour, MD;Jae Park, MD
January 25th 2022
hematologist

EP. 2: Relapsed Refractory B-Cell ALL: Treatment Overview

Elias Jabbour, MD
January 25th 2022
hematologist

EP. 3: CAR T Therapy for Relapsed/Refractory B-Cell ALL: Selecting Appropriate Patients

Elias Jabbour, MD;Jae Park, MD
February 1st 2022
hematologist

EP. 4: CAR-T Therapy for Relapsed/Refractory B-Cell ALL: Sequencing Decisions

Elias Jabbour, MD;Jae Park, MD
February 1st 2022
Jae Park, MD

EP. 5: Relapsed/Refractory B-Cell ALL: CAR-T Safety Profiles

Elias Jabbour, MD;Jae Park, MD
February 8th 2022
Elias Jabbour, MD

EP. 6: Emerging Novel Therapies for Relapsed/Refractory B-Cell ALL

Elias Jabbour, MD
February 8th 2022
acute lymphoblastic leukemia

EP. 7: MRD Assessments in B-Cell ALL

Elias Jabbour, MD;Jae Park, MD
February 15th 2022
acute lymphoblastic leukemia

EP. 8: Relapsed/Refractory B-Cell ALL: Adopting MRD Testing into Routine Practice

Elias Jabbour, MD;Jae Park, MD
February 15th 2022
acute lymphoblastic leukemia

EP. 9: R/R B-Cell ALL: Is There a Role for Transplantation?

Elias Jabbour, MD;Jae Park, MD
February 22nd 2022
hematologist

EP. 10: B-Cell ALL: Integrating Novel Therapies Into Real-World Practice

Elias Jabbour, MD;Jae Park, MD
February 22nd 2022
hematologists

EP. 11: Relapsed/Refractory B-Cell ALL: Future Perspectives

Elias Jabbour, MD;Jae Park, MD
February 22nd 2022